This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
| 329 * | Tue, 8/3/2010, 10:30 AM - 12:20 PM | CC-302/303 (West) |
| The Design and Analysis of Crossover Trials: Some Recent Developments — Topic Contributed Papers | ||
| Biopharmaceutical Section | ||
| Organizer(s): Byron Jones, Pfizer Inc. | ||
| Chair(s): Robb Muirhead, Statistical Scientist | ||
| 10:35 AM | Sample Size Re-estimation in Crossover Trials — Adina Soaita, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Jerry J. Weaver, Pfizer Inc. | |
| 10:55 AM | Scaled Average Bioequivalence for Highly Variable Drugs — Scott Patterson, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Dieter Hauschke, University Medical Center Freiburg | |
| 11:15 AM | Comparing Adaptive and Traditional Crossover Designs for Dose-Finding Trials — James A. Bolognese, Cytel Inc. ; Nitin R. Patel, Cytel Inc. ; Byron Jones, Pfizer Inc. | |
| 11:35 AM | The Use of Baseline Covariates in Cross-Over Studies — Byron Jones, Pfizer Inc. ; Michael G. Kenward, London School of Hygiene and Tropical Medicine ; James Henry Roger, GlaxoSmithKline | |
| 11:55 AM | Optimal Crossover Designs for PK Studies — Sergei Leonov, GlaxoSmithKline ; Valerii Fedorov, GlaxoSmithKline ; Byron Jones, Pfizer Inc. | |
| 12:15 PM | Floor Discussion | |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.